Related Experiment Video
Updated: May 29, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Update on Antiseizure Medications 2025
This updated review covers antiseizure medications for epilepsy management. Newer drugs offer comparable or better efficacy and tolerability than older options, guiding optimal treatment choices.
Area of Science:
- Neurology
- Pharmacology
Background:
- This article updates previous reviews on antiseizure medication (ASM) therapy for epilepsy.
- It covers a wide range of ASMs available for managing patients with epilepsy.
Purpose of the Study:
- To provide an overview of currently available ASMs, detailing their pharmacokinetic properties, indications, and usage.
- To highlight recent FDA approvals and expanded indications for ASMs.
Main Methods:
- Individual review of ASMs, focusing on pharmacokinetics, efficacy, and tolerability.
- Comparison of newer ASMs with older agents in clinical trials.
Main Results:
- Newer ASMs like lamotrigine, oxcarbazepine, levetiracetam, topiramate, zonisamide, and lacosamide show equal or superior efficacy and tolerability for focal epilepsy compared to older drugs.
- Ganaxolone is a newly approved ASM.
- Lacosamide, pregabalin, and eslicarbazepine are effective for conversion to monotherapy in focal epilepsy.
Conclusions:
- Understanding ASM pharmacokinetics, efficacy, and tolerability is crucial for selecting appropriate epilepsy treatments.
- Rational ASM combinations should minimize pharmacokinetic and pharmacodynamic interactions.
More Related Videos
06:45Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists